South Asia shares a common oncologic and immunologic profile,

albeit with some regional differences. Sayre focuses on the SAARC markets of Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, where given the high disease burden, Sayre will contribute to improving the quality of care for cancers and autoimmune conditions, by sustained engagement with physicians and providing affordable healthcare options for patients.
Sayre has robust warehousing & distribution services through its partnership with one of India’s leading pharmaceutical distribution and logistics service providers – India’s first WHO GDP certified in the super specialty segment. The well-established network of distribution centers provide the essential presence of Sayre’s brands and services across the length and breadth of the country.
Sayre has partnered with reputed companies in SAARC to commercialise its assets and with a strong know-how of drug regulations required in SAARC markets. Sayre has identified and fostered valuable relationships with regional partners who have a strong know-how of the local healthcare community with the commercial and medical teams of Sayre overseeing the SAARC operations.